Manulife (Manufacturers Life Insurance)’s Cascadian Therapeutics, Inc. CASC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-8,535
| Closed | -$32K | – | 4431 |
|
|
2017
Q4 | $32K | Buy |
8,535
+6,392
| +298% | +$26.2K | ﹤0.01% | 3670 |
|
|
2017
Q3 | $9K | Buy |
2,143
+1,339
| +167% | +$5.12K | ﹤0.01% | 3892 |
|
|
2017
Q2 | $3K | Buy |
804
+216
| +37% | +$857 | ﹤0.01% | 4092 |
|
|
2017
Q1 | $2K | Hold |
588
| – | – | ﹤0.01% | 3988 |
|
|
2016
Q4 | $3K | Sell |
588
-1
| -0.2% | -$6 | ﹤0.01% | 4082 |
|
|
2016
Q3 | $6K | Hold |
589
| – | – | ﹤0.01% | 3847 |
|
|
2016
Q2 | $3K | Sell |
589
-11,049
| -95% | -$75K | ﹤0.01% | 3966 |
|
|
2016
Q1 | $82K | Buy |
11,638
+963
| +9% | +$7.42K | ﹤0.01% | 3138 |
|
|
2015
Q4 | $142 | Hold |
10,675
| – | – | ﹤0.01% | 2905 |
|
|
2015
Q3 | $176 | Sell |
10,675
-267
| -2% | -$5.47K | ﹤0.01% | 2755 |
|
|
2015
Q2 | $246 | Buy |
10,942
+51
| +0.5% | +$807 | ﹤0.01% | 2692 |
|
|
2015
Q1 | $106 | Buy |
10,891
+5,769
| +113% | +$56.6K | ﹤0.01% | 3145 |
|
|
2014
Q4 | $58 | Sell |
5,122
-3,182
| -38% | -$34.5K | ﹤0.01% | 3199 |
|
|
2014
Q3 | $95 | Sell |
8,304
-12
| -0.1% | -$183 | ﹤0.01% | 3123 |
|
|
2014
Q2 | $162K | Buy |
8,316
+7,901
| +1,904% | +$139K | ﹤0.01% | 2885 |
|
|
2014
Q1 | $7 | Hold |
415
| – | – | ﹤0.01% | 3431 |
|
|
2013
Q4 | $4 | Hold |
415
| – | – | ﹤0.01% | 3599 |
|
|
2013
Q3 | $5 | Hold |
415
| – | – | ﹤0.01% | 3375 |
|
|
2013
Q2 | $4K | Buy |
+415
| New | +$5.33K | ﹤0.01% | 3330 |
|
Manulife (Manufacturers Life Insurance)'s CASC Position: Q1 2018 in Review
Manulife (Manufacturers Life Insurance) sold out of Cascadian Therapeutics, Inc. (CASC) in Q1 2018, closing a stake of 8,535 shares — an estimated $32K sold.
Manulife (Manufacturers Life Insurance) first reported a position in CASC in Q2 2013 and held it in 19 quarters. The position peaked at $162K in Q2 2014. 1 fund tracked by Wall St. Rank holds CASC as of Q1 2018.
- Manulife (Manufacturers Life Insurance) reported no remaining Cascadian Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
- Manulife (Manufacturers Life Insurance) sold 8,535 Cascadian Therapeutics, Inc. shares in Q1 2018, an estimated $32K.
- Manulife (Manufacturers Life Insurance) first reported a position in Cascadian Therapeutics, Inc. in Q2 2013 and held it in 19 quarters.
- Manulife (Manufacturers Life Insurance)'s Cascadian Therapeutics, Inc. position peaked at $162K in Q2 2014.
- 1 fund tracked by Wall St. Rank held Cascadian Therapeutics, Inc. as of Q1 2018.
Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2018, filed 15 May 2018.